New York is nearing a plateau in the number of coronavirus patients hospitalized, a sign of optimism even though the number of the deaths in the state hit a single-day high, Governor Andrew Cuomo said.
As a critical industry during the COVID-19 pandemic, biopharma companies are expected to remain in operation – but with a skeleton staff. Anticipating stay-at-home mandates, life sciences companies and labs in especially hard-hit regions had already begun preparing.
The U.S. Centers for Disease Control and Prevention (CDC) confirmed a second U.S. case of the new coronavirus from China in a Chicago woman, and said as many as 63 potential cases were being investigated as the sometimes deadly illness continues to spread around the globe.
U.S. health officials said there are 530 confirmed and probable cases and seven deaths from severe lung-related illnesses tied to vaping, and there are no signs that the outbreak is easing.
Akorn Inc. received a warning letter from the U.S. Food and Drug Administration following an inspection of the generic drugmaker’s Decatur, Illinois manufacturing plant during 2018.